BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28780640)

  • 1. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
    Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
    Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in cervical cancer mortality rates in Lithuania, 1987-2016.
    Everatt R; Intaitė B
    Cancer Epidemiol; 2018 Dec; 57():85-89. PubMed ID: 30347336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Australian National Cervical Screening Program in women of different ages.
    Smith M; Canfell K
    Med J Aust; 2016 Oct; 205(8):359-364. PubMed ID: 27736623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.
    Bucchi L; Baldacchini F; Mancini S; Ravaioli A; Giuliani O; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N; Biggeri A;
    Int J Cancer; 2019 Mar; 144(5):1017-1026. PubMed ID: 30120770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the National Cervical Cancer Screening Programme in Singapore.
    Jin AZ; Louange EC; Chow KY; Fock CW
    Singapore Med J; 2013 Feb; 54(2):96-101. PubMed ID: 23462834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
    Walker JJ; Brewster D; Gould A; Raab GM
    Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
    Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
    Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia.
    Zielecka-Dębska D; Błaszczyk J; Błaszczyk D; Szelachowska J; Lichoń K; Maciejczyk A; Matkowski R
    Adv Clin Exp Med; 2019 Oct; 28(10):1377-1383. PubMed ID: 31638746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence of, and mortality from, cervical lesions in Ireland: baseline data for future evaluation of the national cervical screening programme.
    O'Brien KM; Sharp L
    Cancer Epidemiol; 2013 Dec; 37(6):830-5. PubMed ID: 24129395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
    Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
    Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Organised' cervical screening 45 years on: How consistent are organised screening practices?
    Williams JH; Carter SM; Rychetnik L
    Eur J Cancer; 2014 Nov; 50(17):3029-38. PubMed ID: 25282406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Time-Trends in Cervical Cancer Mortality in Portugal].
    Teixeira C; Pereira AM; Anes E; Rodrigues C; Castanheira MJ
    Acta Med Port; 2019 Jun; 32(6):427-433. PubMed ID: 31292023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.
    Moon EK; Oh CM; Won YJ; Lee JK; Jung KW; Cho H; Jun JK; Lim MC; Ki M
    Cancer Res Treat; 2017 Apr; 49(2):526-533. PubMed ID: 27586676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in the epidemiology of cervical cancer in South Africa (1994-2012).
    Olorunfemi G; Ndlovu N; Masukume G; Chikandiwa A; Pisa PT; Singh E
    Int J Cancer; 2018 Nov; 143(9):2238-2249. PubMed ID: 29786136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.